AI-Native Scoping Reviews & Evidence Mapping

Benign prostatic hyperplasia may be driven as much by metabolic dysfunction, inflammation, frailty, and lifestyle as by the prostate itself. This review maps the strongest human and experimental evidence—from HDL and fatty liver disease to immune markers, microbiome pathways, and emerging preventive targets—making the full read valuable for anyone seeking the complete prevention landscape.

Multilingual children are often assessed and educated inside systems built around monolingual norms, creating real risks of misdiagnosis, lost heritage-language potential, and unequal educational support. This review shows where multilingualism becomes a clinical challenge, an educational resource, and a misunderstood developmental advantage worth reading in full.

Falsified and substandard medicines are not a marginal pharmacy problem — they are a global public-health threat spanning antimalarials, antibiotics, anticancer agents, cardiovascular drugs, online semaglutide, benzodiazepines, supplements, and emerging synthetic opioids. Unlock the full review to explore 75 mapped references, 103 original studies, prevalence signals up to 59.5%, toxic contamination risks, detection technologies, and the supply-chain gaps that still leave patients exposed.

Pornography is not a single-risk exposure but a complex behavioral ecosystem where most users report neutral or positive effects, while a clinically important minority develop problematic use linked to mental distress, relationship conflict, risky sexual behavior, and aggression-related outcomes. The full read maps 318 references across 1,287 original studies, separating frequency from problematic use and showing where pornography literacy, couple context, moral incongruence, and targeted screening may actually matter.

Surgery does not end when the operation ends: this review shows that across oncology, bariatrics, orthopedics, transplantation, and vascular care, postoperative medication adherence is often the hidden determinant of recurrence, complications, and survival. The full read is worth it because it separates where adherence reliably fails, which barriers drive that failure, and which interventions actually help keep patients on treatment after discharge.

Falsified medical products are not a niche drug-safety problem, but a supply-chain failure spanning medicines, devices, online pharmacies, informal markets, and weak regulatory systems. The full evidence map shows where risk concentrates — from semaglutide and PDE-5 products to vaccines, antibiotics, devices, and digital marketplaces — and which detection, reporting, and regulatory tools can realistically close the gaps.

Mobile health clinics are not just outreach vans; they emerge as equity infrastructure that can bring screening, diagnosis, treatment initiation, and trust directly to populations fixed-site care often misses. The full evidence map shows where MHCs truly deliver value, where continuity breaks down after the first encounter, and which models are most likely to convert access into sustained care.

Transgender fertility care is not a niche issue but a recurring clinical gap: many TGD people want future parenthood, yet fertility preservation remains limited by cost, dysphoria, delayed counseling, and uneven access. The full evidence map helps readers see where fertility potential is preserved, where hormone effects remain uncertain, and how counseling, tissue/gamete preservation, ART, and inclusive care pathways should be clinically structured.